NYSE:AVNS Avanos Medical (AVNS) Stock Price, News & Analysis $24.76 +0.02 (+0.06%) Closing price 05/19/2026 03:59 PM EasternExtended Trading$24.70 -0.06 (-0.24%) As of 09:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Avanos Medical Stock (NYSE:AVNS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Avanos Medical alerts:Sign Up Key Stats Today's Range$24.72▼$24.7750-Day Range$13.05▼$24.8152-Week Range$9.30▼$24.91Volume625,097 shsAverage Volume1.24 million shsMarket Capitalization$1.16 billionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Avanos Medical is a global medical technology company that develops and markets a broad portfolio of medical devices intended to improve patient outcomes in hospital, outpatient and post-acute care settings. The company’s products focus on three core therapy areas—pain management, enteral feeding and respiratory care—designed to help clinicians manage post-operative pain, deliver nutrition support and assist breathing for patients across a variety of acute and chronic conditions. In its pain management segment, Avanos offers both non-opioid drug delivery systems and cryoanalgesia devices, including ambulatory infusion pumps and cooled radiofrequency ablation platforms. These solutions are intended to help reduce reliance on systemic opioids and support accelerated recovery protocols. The enteral feeding business provides a range of feeding tubes, pumps and accessories to deliver nutrition directly to the gastrointestinal tract, serving patients with swallowing disorders or nutritional deficiencies. In respiratory care, the company’s offerings include patient interfaces, breathing circuits and related disposables that aid in noninvasive ventilation, oxygen therapy and airway management. Avanos Medical was established as a standalone company in January 2017 following a spin-off from Kimberly-Clark’s healthcare business. Headquartered in Alpharetta, Georgia, the company maintains a presence in key markets across North America, Europe, Asia Pacific and Latin America. Its global sales and distribution network supports hospitals, surgical centers and home healthcare providers with both direct sales teams and distributor partnerships. Under the leadership of President and Chief Executive Officer Mike Coolbaugh, Avanos pursues a strategy centered on innovation, operational excellence and targeted acquisitions to expand its product portfolio and geographic reach. The company continues to invest in research and development to advance its current offerings and explore new technologies that address evolving clinical needs in pain management, nutritional support and respiratory therapy.AI Generated. May Contain Errors. Read More Avanos Medical Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks12th Percentile Overall ScoreAVNS MarketRank™: Avanos Medical scored higher than 12% of companies evaluated by MarketBeat, and ranked 810th out of 851 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.9 / 5Analyst RatingSell Consensus RatingAvanos Medical has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 2 sell ratings.Amount of Analyst CoverageAvanos Medical has only been the subject of 2 research reports in the past 90 days.Read more about Avanos Medical's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings Growth-13.08% Earnings GrowthEarnings for Avanos Medical are expected to decrease by -13.08% in the coming year, from $1.07 to $0.93 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Avanos Medical is -15.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Avanos Medical is -15.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAvanos Medical has a P/B Ratio of 1.48. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Avanos Medical's valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.65% of the float of Avanos Medical has been sold short.Short Interest Ratio / Days to CoverAvanos Medical has a short interest ratio ("days to cover") of 0.75, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Avanos Medical has recently decreased by 39.59%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAvanos Medical does not currently pay a dividend.Dividend GrowthAvanos Medical does not have a long track record of dividend growth. News and Social Media0.6 / 5News SentimentN/A News SentimentAvanos Medical has a news sentiment score of -1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.38 average news sentiment score of Medical companies.Search InterestOnly 1 people have searched for AVNS on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Avanos Medical insiders have not sold or bought any company stock.Percentage Held by Insiders2.33% of the stock of Avanos Medical is held by insiders.Percentage Held by Institutions95.17% of the stock of Avanos Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Avanos Medical's insider trading history. Receive AVNS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Avanos Medical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AVNS Stock News HeadlinesAvanos Medical, Inc. Announces First Quarter 2026 ResultsMay 5, 2026 | prnewswire.comSummers Value Partners Q1 2026 Partner LetterApril 28, 2026 | seekingalpha.comYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options can give you up to 12 times the leverage of stocks — with a fraction of the capital tied up. This free guide lays it all out in plain English — from A to Z, with step-by-step examples you can follow in your own account.May 20 at 1:00 AM | Profits Run (Ad)Shareholder Alert: Ademi LLP investigates whether Avanos Medical Inc. is obtaining a Fair Price for Public ShareholdersApril 23, 2026 | globenewswire.comIs It Too Late To Consider Buying Avanos Medical (AVNS) After Its Recent Share Price Surge?April 20, 2026 | finance.yahoo.comAvanos Medical Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avanos Medical, Inc. - AVNSApril 15, 2026 | businesswire.comAvanos Medical Stock Looks Capped After American Industrial Partners' OfferApril 15, 2026 | seekingalpha.comAVNS stock records historic intraday surge – everything to know about the buyout deal by American Industrial PartnersApril 14, 2026 | msn.comSee More Headlines AVNS Stock Analysis - Frequently Asked Questions How have AVNS shares performed this year? Avanos Medical's stock was trading at $11.23 at the beginning of 2026. Since then, AVNS shares have increased by 120.4% and is now trading at $24.7550. How were Avanos Medical's earnings last quarter? Avanos Medical, Inc. (NYSE:AVNS) posted its quarterly earnings results on Tuesday, May, 5th. The company reported $0.22 earnings per share for the quarter, topping the consensus estimate of $0.16 by $0.06. Avanos Medical's revenue was up 8.8% compared to the same quarter last year. Who are Avanos Medical's major shareholders? Avanos Medical's top institutional shareholders include Dimensional Fund Advisors LP (4.41%), Punch & Associates Investment Management Inc. (0.93%), Bank of New York Mellon Corp (0.66%) and Principal Financial Group Inc. (0.62%). Insiders that own company stock include Michael Greiner, Gary Blackford, Kerr Holbrook and Julie Ann Shimer. View institutional ownership trends. How do I buy shares of Avanos Medical? Shares of AVNS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Avanos Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Avanos Medical investors own include JPMorgan Chase & Co. (JPM), Meta Platforms (META), NVIDIA (NVDA), Advanced Micro Devices (AMD), Home Depot (HD), Netflix (NFLX) and Tesla (TSLA). Company Calendar Last Earnings5/05/2026Today5/20/2026Next Earnings (Estimated)8/04/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (8m+) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 AVNS's financial health is in the Green zone, according to TradeSmith. AVNS has been in this zone for over 8 months. Industry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry MED INSTRUMENTS Sub-IndustryMedical Equipment Current SymbolNYSE:AVNS CIK1606498 Webavanos.com Phone(844) 428-2667FaxN/AEmployees2,287Year Founded2014Profitability EPS (Trailing Twelve Months)($1.61) Trailing P/E RatioN/A Forward P/E Ratio23.14 P/E GrowthN/ANet Income-$72.90 million Net Margins-10.39% Pretax Margin-9.54% Return on Equity5.39% Return on Assets3.97% Debt Debt-to-Equity Ratio0.11 Current Ratio2.48 Quick Ratio1.40 Sales & Book Value Annual Sales$701.20 million Price / Sales1.65 Cash Flow$3.43 per share Price / Cash Flow7.22 Book Value$16.70 per share Price / Book1.48Miscellaneous Outstanding Shares46,830,000Free Float45,734,000Market Cap$1.16 billion OptionableOptionable Beta1.58 Social Links Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report This page (NYSE:AVNS) was last updated on 5/20/2026 by MarketBeat.com Staff. From Our PartnersHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredI’m sounding the alarmMeta is cutting 10% of its workforce. Microsoft offered voluntary retirement to 7% of U.S. employees. Oracle, ...Porter & Company | SponsoredElon isn't wrong, he's just earlyRobert Kiyosaki, author of Rich Dad Poor Dad with over 40 million copies sold, says universal basic income is ...Freedom Financial | SponsoredYour book attachedVeteran trader Bill Poulos is giving away his 'Simple Options Trading For Beginners' book - normally $29.97 - ...Profits Run | SponsoredThis Biotech Just Flipped From Story to ExecutionAvai Bio (OTCQB: AVAI) has moved into production on its new Master Cell Bank, developed alongside Austrianova,...Equiscreen | SponsoredDistracted Americans set to miss out on quadrillionsTechnology expert and Washington D.C. insider Jeff Brown - who identified Bitcoin, Tesla, and Nvidia early - s...Brownstone Research | SponsoredThe one number Musk can't hide in the S-1When SpaceX files its S-1 in June, one number will stand out - power consumption. Running 1 million GPUs requi...Behind the Markets | SponsoredHow to Access Elon’s “Monster” Interest RateMost Americans earn just 0.4% on their savings - that's $40 a year on $10,000. A new banking alternative is of...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avanos Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avanos Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
